Files

Download

Download Full Text (592 KB)

Date

2019

Abstract

Neonatal Abstinence Syndrome (NAS) is a complex disorder that manifests with neurologic, gastrointestinal, and musculoskeletal disturbances and is most often associated with opioid withdrawal. In the US, 6 out of 1,000 babies are born to mothers who used opioids during their pregnancy. These babies go on to develop NAS. Androscoggin County, where Central Maine Medical Center is located, has an even higher rate of babies with NAS: 100 out of 1,000. Most institutions use the Finnegan Neonatal Abstinence Scoring System (FNASS) to guide pharmacologic treatment. This system assigns a score based on 21 clinical signs of withdrawal with a score ≥8 indicating a need for pharmacologic treatment. This system has never been validated nor has its score cutoffs been tested which may lead to over or under treatment of babies experiencing NAS. Eat, Sleep, Console is a novel approach which has shown to decrease average length of stay, pharmacologic treatment, and healthcare costs.

Clinical Site

Central Maine Medical Center

Keywords

pediatrics, newborn care, neonatal abstinence syndrome, Maine, eat sleep console, opioid withdrawal

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Disciplines

Medical Education | Primary Care

Eat, Sleep, Console for Neonatal Abstinence Syndrome Babies

Share

COinS